Epigenome-Extensive Affiliation Research Reveals Methylation Loci Related With Offspring Gestational Diabetes Mellitus Publicity and Maternal Methylome
Goal: Gestational diabetes mellitus (GDM) is related to an elevated danger of weight problems and insulin resistance in offspring later in life, which could be defined by epigenetic modifications in response to maternal hyperglycemic publicity.
Analysis design and strategies: We explored the affiliation between GDM publicity and maternal blood and new child wire blood methylation in 536 mother-offspring pairs from the possible FinnGeDi cohort utilizing Illumina MethylationEPIC 850Ok BeadChip arrays. We assessed two hypotheses. First, we examined for shared maternal and offspring epigenetic results ensuing from GDM publicity. Second, we examined whether or not GDM publicity and maternal methylation had an epigenetic impact on the offspring.
Outcomes: We didn’t discover any epigenetic marks (differentially methylated CpG probes) with shared and constant results between moms and offspring. After together with maternal methylation within the mannequin, we recognized a single vital (false discovery price 1.38 × 10-2) CpG on the cg22790973 probe (TFCP2) related to GDM. We recognized seven extra FDR-significant interactions of maternal methylation and GDM standing, with the strongest affiliation on the identical cg22790973 probe (TFCP2), in addition to cg03456133, cg24440941 (H3C6), cg20002843 (LOC127841), cg19107264, and cg11493553 situated throughout the UBE3C gene and cg17065901 in FAM13A, each susceptibility genes for sort 2 diabetes and BMI, and cg23355087 throughout the DLGAP2 gene, identified to be concerned in insulin resistance throughout being pregnant.
Conclusions: Our examine reveals the potential complexity of the epigenetic transmission between moms with GDM and their offspring, seemingly decided by not solely GDM publicity but additionally different elements indicated by maternal epigenetic standing, similar to maternal metabolic historical past.
RRAD Antibody |
|||
| 1-CSB-PA003910 | Cusabio |
|
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000 |
|||
RRAD Antibody |
|||
| CSB-PA233809- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
RRAD Antibody |
|||
| CSB-PA233809-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
RRAD Antibody |
|||
| 1-CSB-PA248209 | Cusabio |
|
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100 |
|||
RRAD Antibody |
|||
| GWB-MU399C | GenWay Biotech | 50ug | Ask for price |
RRAD Antibody |
|||
| GWB-MU400D | GenWay Biotech | 50ug | Ask for price |
RRAD Antibody |
|||
| R34275-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
|
Description: Additional name(s) for this target protein: Ras-related associated with diabetes |
|||
RRAD Antibody |
|||
| MBS7132819-01mL | MyBiosource | 0.1mL | EUR 270 |
RRAD Antibody |
|||
| MBS7132819-5x01mL | MyBiosource | 5x0.1mL | EUR 1200 |
RRAD Antibody |
|||
| MBS7128139-005mL | MyBiosource | 0.05mL | EUR 190 |
RRAD Antibody |
|||
| MBS7128139-01mL | MyBiosource | 0.1mL | EUR 270 |
RRAD Antibody |
|||
| MBS7128139-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
RRAD Antibody |
|||
| MBS7128140-005mL | MyBiosource | 0.05mL | EUR 190 |
RRAD Antibody |
|||
| MBS7128140-01mL | MyBiosource | 0.1mL | EUR 270 |
RRAD Antibody |
|||
| MBS7128140-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
RRAD Antibody |
|||
| MBS7116925-005mg | MyBiosource | 0.05mg | EUR 150 |
RRAD Antibody |
|||
| MBS7116925-01mg | MyBiosource | 0.1mg | EUR 190 |
RRAD Antibody |
|||
| MBS7116925-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
RRAD Antibody |
|||
| MBS9412639-01mL | MyBiosource | 0.1mL | EUR 305 |
RRAD Antibody |
|||
| MBS9412639-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
RRAD Antibody |
|||
| MBS9202899-01mL | MyBiosource | 0.1mL | EUR 415 |
RRAD Antibody |
|||
| MBS9202899-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
RRAD Antibody |
|||
| MBS8581027-01mL | MyBiosource | 0.1mL | EUR 305 |
RRAD Antibody |
|||
| MBS8581027-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
RRAD Antibody |
|||
| MBS8581027-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
RRAD Antibody |
|||
| MBS8581027-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
RRAD Antibody |
|||
| MBS8581027-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
RRAD Antibody |
|||
| MBS5314978-01mL | MyBiosource | 0.1mL | EUR 470 |
RRAD Antibody |
|||
| MBS5314978-5x01mL | MyBiosource | 5x0.1mL | EUR 1955 |
Polyclonal RRAD Antibody |
|||
| APR05556G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications: |
|||
RRAD antibody - middle region |
|||
| MBS3212856-01mL | MyBiosource | 0.1mL | EUR 455 |
RRAD antibody - middle region |
|||
| MBS3212856-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
RRAD antibody - middle region |
|||
| MBS3212857-01mL | MyBiosource | 0.1mL | EUR 455 |
RRAD antibody - middle region |
|||
| MBS3212857-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
OAAF03734-100UG - RRAD Antibody |
|||
| OAAF03734-100UG | Aviva Systems Biology | 100ug | EUR 329 |
RRAD Conjugated Antibody |
|||
| C37229 | SAB | 100ul | EUR 476.4 |
RRAD Polyclonal Antibody |
|||
| E-AB-16047-120uL | Elabscience Biotech | 120uL | EUR 240 |
|
Description: Unconjugated |
|||
RRAD Polyclonal Antibody |
|||
| E-AB-16047-200uL | Elabscience Biotech | 200uL | EUR 399 |
|
Description: Unconjugated |
|||
RRAD Polyclonal Antibody |
|||
| E-AB-16047-20uL | Elabscience Biotech | 20uL | EUR 73 |
|
Description: Unconjugated |
|||
RRAD Polyclonal Antibody |
|||
| E-AB-16047-60uL | Elabscience Biotech | 60uL | EUR 143 |
|
Description: Unconjugated |
|||
RRAD Polyclonal Antibody |
|||
| MBS2528424-002mL | MyBiosource | 0.02mL | EUR 140 |
RRAD Polyclonal Antibody |
|||
| MBS2528424-006mL | MyBiosource | 0.06mL | EUR 180 |
RRAD Polyclonal Antibody |
|||
| MBS2528424-012mL | MyBiosource | 0.12mL | EUR 260 |
RRAD Polyclonal Antibody |
|||
| MBS2528424-02mL | MyBiosource | 0.2mL | EUR 405 |
RRAD Polyclonal Antibody |
|||
| MBS2528424-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
RRAD Polyclonal Antibody |
|||
| MBS2528620-002mL | MyBiosource | 0.02mL | EUR 135 |
RRAD Polyclonal Antibody |
|||
| MBS2528620-006mL | MyBiosource | 0.06mL | EUR 190 |
RRAD Polyclonal Antibody |
|||
| MBS2528620-012mL | MyBiosource | 0.12mL | EUR 265 |
RRAD Polyclonal Antibody |
|||
| MBS2528620-02mL | MyBiosource | 0.2mL | EUR 415 |
RRAD Polyclonal Antibody |
|||
| MBS2528620-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
RRAD Conjugated Antibody |
|||
| MBS9447672-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
RRAD Conjugated Antibody |
|||
| MBS9447672-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
RRAD Conjugated Antibody |
|||
| MBS9447672-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
RRAD Conjugated Antibody |
|||
| MBS9447672-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
RRAD Conjugated Antibody |
|||
| MBS9447672-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
RRAD Polyclonal Antibody |
|||
| RD78747A-120uL | Reddot Biotech | 120μL | EUR 360 |
|
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney. |
|||
RRAD Polyclonal Antibody |
|||
| RD78747A-200uL | Reddot Biotech | 200μL | EUR 630 |
|
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney. |
|||
RRAD Polyclonal Antibody |
|||
| RD78747A-20uL | Reddot Biotech | 20μL | EUR 109.5 |
|
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney. |
|||
RRAD Polyclonal Antibody |
|||
| RD78747A-60uL | Reddot Biotech | 60μL | EUR 214.5 |
|
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney. |
|||
RRAD Rabbit Polyclonal Antibody |
|||
| E10G04435 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
RRAD Rabbit Polyclonal Antibody |
|||
| E10G11330 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GTP-Binding Protein RAD (RRAD) Antibody |
|||
| 20-abx008742 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
| 20-abx214509 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx332370-100ul | Abbexa | 100 ul | EUR 510 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| 20-abx324872 | Abbexa |
|
|
GTP-Binding Protein RAD (RRAD) Antibody |
|||
| abx432011-200ul | Abbexa | 200 ul | EUR 460.8 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| 20-abx241706 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx241706-96tests | Abbexa | 96 tests | EUR 250 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx214509-100tests | Abbexa | 100 tests | EUR 350 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx214509-200tests | Abbexa | 200 tests | Ask for price |
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx214509-20tests | Abbexa | 20 tests | EUR 250 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx324872-100g | Abbexa | 100 µg | EUR 250 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx324872-50g | Abbexa | 50 µg | EUR 187.5 |
GTP-Binding Protein RAD (RRAD) Antibody |
|||
| abx432011-100g | Abbexa | 100 µg | EUR 387.5 |
ARP56566_P050-25UL - RRAD Antibody - middle region |
|||
| ARP56566_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP56567_P050-25UL - RRAD Antibody - middle region |
|||
| ARP56567_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
OASG06195-100UL - RRAD Antibody - middle region |
|||
| OASG06195-100UL | Aviva Systems Biology | 100ul | EUR 239 |
OAEB02919-100UG - RRAD Antibody - middle region |
|||
| OAEB02919-100UG | Aviva Systems Biology | 100ug | EUR 349 |
ARP56566_P050 - RRAD antibody - middle region (ARP56566_P050) |
|||
| ARP56566_P050 | Aviva Systems Biology | 100ul | EUR 389 |
ARP56567_P050 - RRAD antibody - middle region (ARP56567_P050) |
|||
| ARP56567_P050 | Aviva Systems Biology | 100ul | EUR 389 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx122938-100ug | Abbexa | 100 ug | EUR 469.2 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx237237-100ug | Abbexa | 100 ug | EUR 661.2 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx122938-100l | Abbexa | 100 µl | Ask for price |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx122938-20l | Abbexa | 20 µl | EUR 337.5 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx122938-50l | Abbexa | 50 µl | Ask for price |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx237237-100g | Abbexa | 100 µg | EUR 350 |
Polyclonal RRAD (aa36-48) Antibody (internal region) |
|||
| APG00807G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human RRAD (aa36-48) (internal region). This antibody is tested and proven to work in the following applications: |
|||
RRAD siRNA |
|||
| 20-abx932133 | Abbexa |
|
|
RRAD Peptide |
|||
| 43-008P | ProSci | 0.1 mg | EUR 405.6 |
|
Description: RRAD Peptide |
|||
RRAD Rabbit anti-Human Polyclonal (aa107-156) Antibody |
|||
| MBS2402152-005mL | MyBiosource | 0.05mL | EUR 615 |
RRAD Rabbit anti-Human Polyclonal (aa107-156) Antibody |
|||
| MBS2402152-5x005mL | MyBiosource | 5x0.05mL | EUR 2605 |
RRAD siRNA (Human) |
|||
| MBS8215484-15nmol | MyBiosource | 15nmol | EUR 405 |
RRAD siRNA (Human) |
|||
| MBS8215484-30nmol | MyBiosource | 30nmol | EUR 565 |
RRAD siRNA (Human) |
|||
| MBS8215484-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
RRAD Blocking Peptide |
|||
| 20-abx063234 | Abbexa |
|
|
RRAD Blocking Peptide |
|||
| 33R-10070 | Fitzgerald | 100 ug | EUR 119 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5798 |
|||
RRAD Blocking Peptide |
|||
| 33R-4793 | Fitzgerald | 100 ug | EUR 119 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797 |
|||
RRAD Blocking Peptide |
|||
| MBS823418-1mg | MyBiosource | 1mg | EUR 190 |
RRAD Blocking Peptide |
|||
| MBS823418-5mg | MyBiosource | 5mg | EUR 345 |
RRAD Blocking Peptide |
|||
| MBS823418-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
RRAD Immunizing Peptide |
|||
| MBS427795-01mg | MyBiosource | 0.1mg | EUR 225 |
Rrad (GFP-tagged) - Mouse Ras-related associated with diabetes (Rrad) |
|||
| MG204351 | Origene Technologies GmbH | 10 µg | Ask for price |
Rrad (untagged) - Mouse Ras-related associated with diabetes (Rrad), (10ug) |
|||
| MC203288 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (NM_001128850) Human Recombinant Protein |
|||
| PROTP55042 | BosterBio | 20ug | EUR 1249 |
|
Description: Recombinant protein of human Ras-related associated with diabetes (RRAD), transcript variant 1 |
|||
Rat Rrad ELISA Kit |
|||
| ELI-14921r | Nova Lifetech | 96tests | EUR 756 |
Rat Rrad ELISA Kit |
|||
| EF019253 | Nova Lifetech | 96tests | EUR 566 |
Mouse Rrad ELISA Kit |
|||
| EF016057 | Nova Lifetech | 96tests | EUR 566 |
Human RRAD ELISA KIT |
|||
| EF005507 | Nova Lifetech | 96tests | EUR 566 |
Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad) |
|||
| MR204351 | Origene Technologies GmbH | 10 µg | Ask for price |
Human RRAD shRNA Plasmid |
|||
| 20-abx954199 | Abbexa |
|
|
Rrad (untagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug) |
|||
| RN208148 | Origene Technologies GmbH | 10 µg | Ask for price |
Human RRAD Protein Lysate |
|||
| MBS8418875-002mg | MyBiosource | 0.02mg | EUR 365 |
Human RRAD Protein Lysate |
|||
| MBS8418875-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
RRAD Peptide - middle region |
|||
| MBS3237802-01mg | MyBiosource | 0.1mg | EUR 180 |
RRAD Peptide - middle region |
|||
| MBS3237802-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
RRAD Peptide - middle region |
|||
| MBS3237803-01mg | MyBiosource | 0.1mg | EUR 180 |
RRAD Peptide - middle region |
|||
| MBS3237803-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
RRAD (NM_001128850) Human Over-expression Lysate |
|||
| LS006236 | BosterBio | 100ug | EUR 628 |
|
Description: Transient overexpression lysate of Ras-related associated with diabetes (RRAD) |
|||
RRAD Recombinant Protein (Rat) |
|||
| RP226925 | ABM | 100 ug | Ask for price |
RRAD Recombinant Protein (Human) |
|||
| RP095493 | ABM | 100 ug | Ask for price |
RRAD Recombinant Protein (Mouse) |
|||
| RP169340 | ABM | 100 ug | Ask for price |
RRAD (untagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 1 |
|||
| SC322965 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (untagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 2 |
|||
| SC117559 | Origene Technologies GmbH | 10 µg | Ask for price |
Rrad ORF Vector (Rat) (pORF) |
|||
| ORF075643 | ABM | 1.0 ug DNA | EUR 607.2 |
RRAD ORF Vector (Human) (pORF) |
|||
| ORF031832 | ABM | 1.0 ug DNA | EUR 486 |
Rrad ORF Vector (Mouse) (pORF) |
|||
| ORF056448 | ABM | 1.0 ug DNA | EUR 607.2 |
RRAD (GFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 1 |
|||
| RG225433 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (GFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 2 |
|||
| RG202927 | Origene Technologies GmbH | 10 µg | Ask for price |
Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug) |
|||
| RR208148 | Origene Technologies GmbH | 10 µg | Ask for price |
Human RRAD knockout cell line |
|||
| ABC-KH13200 | AcceGen | 1 vial | Ask for price |
|
Description: Human RRAD knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
Human RRAD knockdown cell line |
|||
| ABC-KD13200 | AcceGen | 1 vial | Ask for price |
|
Description: Human RRAD knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
Human RRAD Protein Lysate 20ug |
|||
| IHURRADPLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human RRAD Protein Lysate 20ug |
|||
Lenti ORF clone of Rrad (mGFP-tagged) - Mouse Ras-related associated with diabetes (Rrad) |
|||
| MR204351L4 | Origene Technologies GmbH | 10 µg | Ask for price |
OCOA18635-20UG - RRAD Protein Lysate |
|||
| OCOA18635-20UG | Aviva Systems Biology | 20ug | EUR 169 |
OCOA13236-20UG - RRAD Protein Lysate |
|||
| OCOA13236-20UG | Aviva Systems Biology | 20ug | EUR 169 |
RRAD (Myc-DDK-tagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 2 |
|||
| RC202927 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (Myc-DDK-tagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 1 |
|||
| RC225433 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad) |
|||
| MR204351L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Rrad (GFP-tagged) - Mouse Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL |
|||
| MR204351L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Rrad sgRNA CRISPR Lentivector set (Rat) |
|||
| K7052701 | ABM | 3 x 1.0 ug | EUR 406.8 |
Lenti ORF particles, Rrad (GFP-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL |
|||
| RR208148L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Rrad (mGFP-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug) |
|||
| RR208148L4 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD sgRNA CRISPR Lentivector set (Human) |
|||
| K2069901 | ABM | 3 x 1.0 ug | EUR 406.8 |
Rrad sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3480701 | ABM | 3 x 1.0 ug | EUR 406.8 |
Lenti ORF particles, Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL |
|||
| MR204351L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Rrad 3'UTR GFP Stable Cell Line |
|||
| TU168183 | ABM | 1.0 ml | Ask for price |
Rrad 3'UTR GFP Stable Cell Line |
|||
| TU269725 | ABM | 1.0 ml | Ask for price |
RRAD 3'UTR GFP Stable Cell Line |
|||
| TU072380 | ABM | 1.0 ml | EUR 1672.8 |
AAP56566-100UG - RRAD Peptide - middle region |
|||
| AAP56566-100UG | Aviva Systems Biology | 100ug | EUR 99 |
AAP56567-100UG - RRAD Peptide - middle region |
|||
| AAP56567-100UG | Aviva Systems Biology | 100ug | EUR 99 |
Recombinant Human RRAD protein, His-tagged |
|||
| RRAD-2818H | Creative BioMart | 25ug | EUR 255.2 |
|
Description: Short-term storage: Store at 2-8°C for (1-2 weeks). Long-term storage: Aliquot and store at -20°C to -80°C for up to 3 months, buffer containing 50% glycerol is recommended for reconstitution. Avoid repeat freeze-thaw cycles. |
|||
Lenti ORF particles, Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL |
|||
| RR208148L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug) |
|||
| RR208148L3 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD Protein Vector (Rat) (pPM-C-HA) |
|||
| PV302572 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Rat) (pPB-C-His) |
|||
| PV302570 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Rat) (pPB-N-His) |
|||
| PV302571 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Rat) (pPM-C-His) |
|||
| PV302573 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Human) (pPM-C-HA) |
|||
| PV127328 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV225792 | ABM | 500 ng | EUR 723.6 |
Anti-RRAD Antibody |
|||
| MBS821944-003mL | MyBiosource | 0.03mL | EUR 185 |
Anti-RRAD Antibody |
|||
| MBS821944-01mL | MyBiosource | 0.1mL | EUR 255 |
Anti-RRAD Antibody |
|||
| MBS821944-02mL | MyBiosource | 0.2mL | EUR 335 |
Anti-RRAD Antibody |
|||
| MBS821944-5x02mL | MyBiosource | 5x0.2mL | EUR 1420 |
RRAD 3'UTR Luciferase Stable Cell Line |
|||
| TU022380 | ABM | 1.0 ml | EUR 1672.8 |
Rrad 3'UTR Luciferase Stable Cell Line |
|||
| TU118183 | ABM | 1.0 ml | Ask for price |
RRAD Protein Vector (Human) (pPB-C-His) |
|||
| PV127326 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Human) (pPB-N-His) |
|||
| PV127327 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Human) (pPM-C-His) |
|||
| PV127329 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Mouse) (pPB-C-His) |
|||
| PV225790 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Mouse) (pPB-N-His) |
|||
| PV225791 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Mouse) (pPM-C-His) |
|||
| PV225793 | ABM | 500 ng | EUR 723.6 |
Rrad 3'UTR Luciferase Stable Cell Line |
|||
| TU219725 | ABM | 1.0 ml | Ask for price |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K7052702 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K7052703 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K7052704 | ABM | 1.0 ug DNA | EUR 184.8 |
RRAD sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K2069902 | ABM | 1.0 ug DNA | EUR 184.8 |
RRAD sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K2069903 | ABM | 1.0 ug DNA | EUR 184.8 |
RRAD sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K2069904 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K3480702 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K3480703 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K3480704 | ABM | 1.0 ug DNA | EUR 184.8 |
Recombinant Rat GTP-binding protein RAD (Rrad) |
|||
| MBS957969-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1185 |
Recombinant Rat GTP-binding protein RAD (Rrad) |
|||
| MBS957969-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 830 |
Recombinant Rat GTP-binding protein RAD (Rrad) |
|||
| MBS957969-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 975 |
Recombinant Rat GTP-binding protein RAD (Rrad) |
|||
| MBS957969-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 995 |
Recombinant Rat GTP-binding protein RAD (Rrad) |
|||
| MBS957969-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1140 |
Recombinant Mouse GTP-binding protein RAD (Rrad) |
|||
| MBS1061990-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1185 |
Recombinant Mouse GTP-binding protein RAD (Rrad) |
|||
| MBS1061990-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 835 |
Recombinant Mouse GTP-binding protein RAD (Rrad) |
|||
| MBS1061990-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 975 |
Recombinant Mouse GTP-binding protein RAD (Rrad) |
|||
| MBS1061990-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1000 |
Recombinant Mouse GTP-binding protein RAD (Rrad) |
|||
| MBS1061990-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1120 |
Recombinant Human GTP-binding protein RAD (RRAD) |
|||
| MBS965065-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1185 |
Recombinant Human GTP-binding protein RAD (RRAD) |
|||
| MBS965065-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 835 |
Recombinant Human GTP-binding protein RAD (RRAD) |
|||
| MBS965065-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 975 |
Recombinant Human GTP-binding protein RAD (RRAD) |
|||
| MBS965065-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1000 |
Recombinant Human GTP-binding protein RAD (RRAD) |
|||
| MBS965065-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1120 |
Rat GTP-binding protein RAD (RRAD) ELISA Kit |
|||
| abx391893-96tests | Abbexa | 96 tests | EUR 1093.2 |
Human GTP- binding protein RAD, RRAD ELISA KIT |
|||
| ELI-35549h | Nova Lifetech | 96tests | EUR 696 |
Metformin use is related to a decreased danger of acute appendicitis in Taiwanese sufferers with sort 2 diabetes mellitus
This retrospective cohort examine used the nationwide database of Taiwan’s Nationwide Well being Insurance coverage to analyze whether or not metformin would cut back the chance of acute appendicitis in sufferers with sort 2 diabetes mellitus. We first recognized 423,949 sufferers newly recognized of diabetes from 1999 to 2005. After excluding sufferers having sort 1 diabetes mellitus, lacking knowledge, earlier historical past of acute appendicitis, aged < 15 years, aged > 80 years and adopted up for < 6 months, 338,172 ever customers and 21,861 by no means customers of metformin had been adopted up from January 1, 2006 till December 31, 2011.
Incidence of acute appendicitis was estimated for by no means customers, ever customers and subgroups (divided by median, tertiles and quartiles, respectively) of dose-response indicators together with cumulative period (months), cumulative dose (mg) and common day by day dose (mg/day) of metformin remedy. We used Cox regression included with the inverse chance of remedy weighting utilizing propensity rating to estimate the general hazard ratio for ever versus by no means customers, and the hazard ratios for subgroups of dose-response indicators versus by no means customers.
Outcomes confirmed that new-onset acute appendicitis was recognized in 1558 ever customers and 179 by no means customers throughout follow-up. The incidence was 98.15 per 100,000 person-years in ever customers and was 189.48 per 100,000 person-years in by no means customers. The general hazard ratio (95% confidence interval) of 0.514 (0.441-0.600) instructed a decrease danger of acute appendicitis related to metformin use. A dose-response sample was constantly noticed within the analyses of various subgroups of dose-response indicators and the decreased danger related to metformin use was constantly noticed in numerous sensitivity analyses.
A median day by day dose of 1000-1500 mg/day can considerably scale back the chance by > 50%. The profit didn’t differ between totally different formulations of metformin, and the estimated hazard ratio for standard/immediate-release metformin versus by no means customers was 0.516 (0.441-0.603) and was 0.509 (0.421-0.615) for extended/slow-release metformin versus by no means customers. It’s concluded that metformin use is related to a decreased danger of acute appendicitis in sufferers with sort 2 diabetes mellitus.
Affiliation of severity of diabetic retinopathy with corneal endothelial and thickness modifications in sufferers with diabetes mellitus
Goal: To analyse the central corneal thickness, endothelial cell density and morphology in sufferers with diabetes mellitus (DM).
Strategies: We analysed corneal endothelium, i.e. central corneal thickness (CCT), endothelial cell density (ECD), coefficient of variation in cell measurement (CV), and hexagonality (Hex) with specular microscopy in sufferers with sort 2 DM and in contrast with age-matched controls. The affect of diabetic retinopathy (DR) severity, period of DM, and degree of glycosylated haemoglobin (HbA1c) was additionally analysed.
Outcomes: The examine cohort included 592 eyes of 592 diabetic sufferers and 596 eyes of 596 management topics. A big distinction was present in CCT (522.1 ± 36.6 μm in DM, 514.9 ± 37.1 μm in controls; P = 0.001), ECD (2484.5 ± 299.5 cells/mm2 in DM, 2555.9 ± 258.2 cells/mm2 in controls; P = 0.017), CV (40.3 ± 6.1 in DM, 37.2 ± 6.1 in controls; P < 0.001) and Hex (39.9 ± 5.2 in DM, 44.6 ± 6.Zero in controls; P < 0.001). The longer period of DM ( > 10 years) and poor glycaemic management (HbA1c > 7.5%) had been related to related outcomes. A considerably decreased ECD (P < 0.001) and Hex (P = 0.001) and better CV (P = 0.007) and CCT (P = 0.01) was famous when assessed towards numerous phases of DR. Multivariate evaluation confirmed that growing age was considerably related to decrease ECD (P < 0.001), Hex (P < 0.001), and CCT (P = 0.004); and the next CV (P < 0.001).
Conclusions: DM has deleterious results on corneal endothelium and thickness. The presence of DR might additional warrant a radical corneal analysis, particularly when planning intraocular surgical procedure.
Affiliation of interior retinal reflectivity with qualitative and quantitative modifications in retinal layers over time in diabetic eyes with out retinopathy
Goal: To evaluate the course of neurodegeneration primarily based on retinal layer thickness and integrity evaluation in diabetic sufferers with out retinopathy and to judge its affiliation with interior retinal reflectivity.
Strategies: This retrospective case-control examine included 80 eyes of 80 sufferers with DM with out retinopathy and 40 eyes of 40 wholesome topics with a follow-up of ≥1 12 months. SD-OCT was used for evaluation of retinal reflectivity and macular layer thicknesses. Optical depth ratios (OIRs) had been outlined because the imply OCT reflectivity of ganglion cell and interior nuclear layer to the imply reflectivity of RPE.
Outcomes: After Bonferroni correction, thinning in pericentral, superior and nasal sectors in whole retina, superior ganglion cell, pericentral and nasal interior plexiform, and superior interior retinal layers, in addition to thickening in inferior and pericentral outer plexiform layer remained vital within the examine group (p < 0.0125). Ganglion cell layer OIR considerably correlated with the modifications in superior retina (r = 0.278, p = 0.013), central interior retina (r = 0.247, p = 0.027), and pericentral retinal thickness (r = 0.240, p = 0.032), and no eyes had disruption of retinal layers within the examine group initially or lastly.
Conclusion: Ganglion cell layer reflectivity considerably correlated with the quantity of pericentral retinal thinning through the time course within the diabetic group, which was extra outstanding within the interior retinal layers.
RRAD Antibody |
|||
| E38PA2040 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
RRAD antibody |
|||
| 70R-5797 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal RRAD antibody raised against the middle region of RRAD |
|||
RRAD antibody |
|||
| 70R-5798 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal RRAD antibody raised against the middle region of RRAD |
|||
RRAD antibody |
|||
| 70R-50359 | Fitzgerald | 100 ul | EUR 242 |
|
Description: Purified Polyclonal RRAD antibody |
|||
RRAD Antibody |
|||
| 1-CSB-PA003910 | Cusabio |
|
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000 |
|||
RRAD Antibody |
|||
| CSB-PA233809- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
RRAD Antibody |
|||
| CSB-PA233809-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
RRAD Antibody |
|||
| 1-CSB-PA248209 | Cusabio |
|
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100 |
|||
RRAD Antibody |
|||
| GWB-MU399C | GenWay Biotech | 50ug | Ask for price |
RRAD Antibody |
|||
| GWB-MU400D | GenWay Biotech | 50ug | Ask for price |
RRAD Antibody |
|||
| R34275-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
|
Description: Additional name(s) for this target protein: Ras-related associated with diabetes |
|||
RRAD Antibody |
|||
| MBS7132819-01mL | MyBiosource | 0.1mL | EUR 270 |
RRAD Antibody |
|||
| MBS7132819-5x01mL | MyBiosource | 5x0.1mL | EUR 1200 |
RRAD Antibody |
|||
| MBS7128139-005mL | MyBiosource | 0.05mL | EUR 190 |
RRAD Antibody |
|||
| MBS7128139-01mL | MyBiosource | 0.1mL | EUR 270 |
RRAD Antibody |
|||
| MBS7128139-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
RRAD Antibody |
|||
| MBS7128140-005mL | MyBiosource | 0.05mL | EUR 190 |
RRAD Antibody |
|||
| MBS7128140-01mL | MyBiosource | 0.1mL | EUR 270 |
RRAD Antibody |
|||
| MBS7128140-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
RRAD Antibody |
|||
| MBS7116925-005mg | MyBiosource | 0.05mg | EUR 150 |
RRAD Antibody |
|||
| MBS7116925-01mg | MyBiosource | 0.1mg | EUR 190 |
RRAD Antibody |
|||
| MBS7116925-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
RRAD Antibody |
|||
| MBS9412639-01mL | MyBiosource | 0.1mL | EUR 305 |
RRAD Antibody |
|||
| MBS9412639-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
RRAD Antibody |
|||
| MBS9202899-01mL | MyBiosource | 0.1mL | EUR 415 |
RRAD Antibody |
|||
| MBS9202899-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
RRAD Antibody |
|||
| MBS8581027-01mL | MyBiosource | 0.1mL | EUR 305 |
RRAD Antibody |
|||
| MBS8581027-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
RRAD Antibody |
|||
| MBS8581027-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
RRAD Antibody |
|||
| MBS8581027-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
RRAD Antibody |
|||
| MBS8581027-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
RRAD Antibody |
|||
| MBS5314978-01mL | MyBiosource | 0.1mL | EUR 470 |
RRAD Antibody |
|||
| MBS5314978-5x01mL | MyBiosource | 5x0.1mL | EUR 1955 |
Polyclonal RRAD Antibody |
|||
| APR05556G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications: |
|||
RRAD antibody - middle region |
|||
| MBS3212856-01mL | MyBiosource | 0.1mL | EUR 455 |
RRAD antibody - middle region |
|||
| MBS3212856-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
RRAD antibody - middle region |
|||
| MBS3212857-01mL | MyBiosource | 0.1mL | EUR 455 |
RRAD antibody - middle region |
|||
| MBS3212857-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
OAAF03734-100UG - RRAD Antibody |
|||
| OAAF03734-100UG | Aviva Systems Biology | 100ug | EUR 329 |
RRAD Conjugated Antibody |
|||
| C37229 | SAB | 100ul | EUR 476.4 |
RRAD Polyclonal Antibody |
|||
| E-AB-16047-120uL | Elabscience Biotech | 120uL | EUR 240 |
|
Description: Unconjugated |
|||
RRAD Polyclonal Antibody |
|||
| E-AB-16047-200uL | Elabscience Biotech | 200uL | EUR 399 |
|
Description: Unconjugated |
|||
RRAD Polyclonal Antibody |
|||
| E-AB-16047-20uL | Elabscience Biotech | 20uL | EUR 73 |
|
Description: Unconjugated |
|||
RRAD Polyclonal Antibody |
|||
| E-AB-16047-60uL | Elabscience Biotech | 60uL | EUR 143 |
|
Description: Unconjugated |
|||
RRAD Polyclonal Antibody |
|||
| MBS2528424-002mL | MyBiosource | 0.02mL | EUR 140 |
RRAD Polyclonal Antibody |
|||
| MBS2528424-006mL | MyBiosource | 0.06mL | EUR 180 |
RRAD Polyclonal Antibody |
|||
| MBS2528424-012mL | MyBiosource | 0.12mL | EUR 260 |
RRAD Polyclonal Antibody |
|||
| MBS2528424-02mL | MyBiosource | 0.2mL | EUR 405 |
RRAD Polyclonal Antibody |
|||
| MBS2528424-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
RRAD Polyclonal Antibody |
|||
| MBS2528620-002mL | MyBiosource | 0.02mL | EUR 135 |
RRAD Polyclonal Antibody |
|||
| MBS2528620-006mL | MyBiosource | 0.06mL | EUR 190 |
RRAD Polyclonal Antibody |
|||
| MBS2528620-012mL | MyBiosource | 0.12mL | EUR 265 |
RRAD Polyclonal Antibody |
|||
| MBS2528620-02mL | MyBiosource | 0.2mL | EUR 415 |
RRAD Polyclonal Antibody |
|||
| MBS2528620-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
RRAD Conjugated Antibody |
|||
| MBS9447672-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
RRAD Conjugated Antibody |
|||
| MBS9447672-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
RRAD Conjugated Antibody |
|||
| MBS9447672-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
RRAD Conjugated Antibody |
|||
| MBS9447672-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
RRAD Conjugated Antibody |
|||
| MBS9447672-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
RRAD Polyclonal Antibody |
|||
| RD78747A-120uL | Reddot Biotech | 120μL | EUR 360 |
|
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney. |
|||
RRAD Polyclonal Antibody |
|||
| RD78747A-200uL | Reddot Biotech | 200μL | EUR 630 |
|
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney. |
|||
RRAD Polyclonal Antibody |
|||
| RD78747A-20uL | Reddot Biotech | 20μL | EUR 109.5 |
|
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney. |
|||
RRAD Polyclonal Antibody |
|||
| RD78747A-60uL | Reddot Biotech | 60μL | EUR 214.5 |
|
Description: The protein may be important in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. As regulator of voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway and phosphorylation and activation of CAMK2D. Mostly expressed in the heart and muscle of type II diabetic humans. Also found in the skeletal muscle, lung and adipose tissue. Lesser amounts in placenta and kidney. |
|||
RRAD Rabbit Polyclonal Antibody |
|||
| E10G04435 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
RRAD Rabbit Polyclonal Antibody |
|||
| E10G11330 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GTP-Binding Protein RAD (RRAD) Antibody |
|||
| 20-abx008742 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
| 20-abx214509 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx332370-100ul | Abbexa | 100 ul | EUR 510 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| 20-abx324872 | Abbexa |
|
|
GTP-Binding Protein RAD (RRAD) Antibody |
|||
| abx432011-200ul | Abbexa | 200 ul | EUR 460.8 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| 20-abx241706 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx241706-96tests | Abbexa | 96 tests | EUR 250 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx214509-100tests | Abbexa | 100 tests | EUR 350 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx214509-200tests | Abbexa | 200 tests | Ask for price |
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx214509-20tests | Abbexa | 20 tests | EUR 250 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx324872-100g | Abbexa | 100 µg | EUR 250 |
GTP-binding protein RAD (RRAD) Antibody |
|||
| abx324872-50g | Abbexa | 50 µg | EUR 187.5 |
GTP-Binding Protein RAD (RRAD) Antibody |
|||
| abx432011-100g | Abbexa | 100 µg | EUR 387.5 |
ARP56566_P050-25UL - RRAD Antibody - middle region |
|||
| ARP56566_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP56567_P050-25UL - RRAD Antibody - middle region |
|||
| ARP56567_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
OASG06195-100UL - RRAD Antibody - middle region |
|||
| OASG06195-100UL | Aviva Systems Biology | 100ul | EUR 239 |
OAEB02919-100UG - RRAD Antibody - middle region |
|||
| OAEB02919-100UG | Aviva Systems Biology | 100ug | EUR 349 |
ARP56566_P050 - RRAD antibody - middle region (ARP56566_P050) |
|||
| ARP56566_P050 | Aviva Systems Biology | 100ul | EUR 389 |
ARP56567_P050 - RRAD antibody - middle region (ARP56567_P050) |
|||
| ARP56567_P050 | Aviva Systems Biology | 100ul | EUR 389 |
RRAD Rabbit anti-Human Polyclonal (aa107-156) Antibody |
|||
| MBS2402152-005mL | MyBiosource | 0.05mL | EUR 615 |
RRAD Rabbit anti-Human Polyclonal (aa107-156) Antibody |
|||
| MBS2402152-5x005mL | MyBiosource | 5x0.05mL | EUR 2605 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx122938-100ug | Abbexa | 100 ug | EUR 469.2 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx237237-100ug | Abbexa | 100 ug | EUR 661.2 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx122938-100l | Abbexa | 100 µl | Ask for price |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx122938-20l | Abbexa | 20 µl | EUR 337.5 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx122938-50l | Abbexa | 50 µl | Ask for price |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
| abx237237-100g | Abbexa | 100 µg | EUR 350 |
Polyclonal RRAD (aa36-48) Antibody (internal region) |
|||
| APG00807G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human RRAD (aa36-48) (internal region). This antibody is tested and proven to work in the following applications: |
|||
Anti-RRAD Antibody |
|||
| MBS821944-003mL | MyBiosource | 0.03mL | EUR 185 |
Anti-RRAD Antibody |
|||
| MBS821944-01mL | MyBiosource | 0.1mL | EUR 255 |
Anti-RRAD Antibody |
|||
| MBS821944-02mL | MyBiosource | 0.2mL | EUR 335 |
Anti-RRAD Antibody |
|||
| MBS821944-5x02mL | MyBiosource | 5x0.2mL | EUR 1420 |
RRAD siRNA |
|||
| 20-abx932133 | Abbexa |
|
|
RRAD Peptide |
|||
| 43-008P | ProSci | 0.1 mg | EUR 405.6 |
|
Description: RRAD Peptide |
|||
Rabbit anti-RRAD Antibody |
|||
| DL91040A-100ul | DL Develop | 100 ul | EUR 336 |
|
Description: RAD; GTP-binding protein RAD; RAD1; Ras associated with diabetes |
|||
Rabbit anti-RRAD Antibody |
|||
| DL91040A-50ul | DL Develop | 50 ul | EUR 235.2 |
|
Description: RAD; GTP-binding protein RAD; RAD1; Ras associated with diabetes |
|||
Rabbit anti-RRAD Antibody |
|||
| YLD6918-100ul | Shanghai YL Biotech | 100 ul | EUR 320 |
|
Description: Rabbit polyclonal antibody to RRAD |
|||
Rabbit anti-RRAD Antibody |
|||
| YLD6918-50ul | Shanghai YL Biotech | 50 ul | EUR 200 |
|
Description: Rabbit polyclonal antibody to RRAD |
|||
RRAD siRNA (Human) |
|||
| MBS8215484-15nmol | MyBiosource | 15nmol | EUR 405 |
RRAD siRNA (Human) |
|||
| MBS8215484-30nmol | MyBiosource | 30nmol | EUR 565 |
RRAD siRNA (Human) |
|||
| MBS8215484-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
RRAD Blocking Peptide |
|||
| 20-abx063234 | Abbexa |
|
|
RRAD Blocking Peptide |
|||
| 33R-10070 | Fitzgerald | 100 ug | EUR 119 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5798 |
|||
RRAD Blocking Peptide |
|||
| 33R-4793 | Fitzgerald | 100 ug | EUR 119 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797 |
|||
RRAD Blocking Peptide |
|||
| MBS823418-1mg | MyBiosource | 1mg | EUR 190 |
RRAD Blocking Peptide |
|||
| MBS823418-5mg | MyBiosource | 5mg | EUR 345 |
RRAD Blocking Peptide |
|||
| MBS823418-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
RRAD Immunizing Peptide |
|||
| MBS427795-01mg | MyBiosource | 0.1mg | EUR 225 |
Rrad (GFP-tagged) - Mouse Ras-related associated with diabetes (Rrad) |
|||
| MG204351 | Origene Technologies GmbH | 10 µg | Ask for price |
Rrad (untagged) - Mouse Ras-related associated with diabetes (Rrad), (10ug) |
|||
| MC203288 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (NM_001128850) Human Recombinant Protein |
|||
| PROTP55042 | BosterBio | 20ug | EUR 1249 |
|
Description: Recombinant protein of human Ras-related associated with diabetes (RRAD), transcript variant 1 |
|||
Anti-RRAD (aa36-48) antibody |
|||
| STJ72757 | St John's Laboratory | 100 µg | EUR 430.8 |
Rat Rrad ELISA Kit |
|||
| ELI-14921r | Nova Lifetech | 96tests | EUR 756 |
Rat Rrad ELISA Kit |
|||
| EF019253 | Nova Lifetech | 96tests | EUR 566 |
Anti-RRAD Rabbit Polyclonal Antibody |
|||
| TA322781 | Origene Technologies GmbH | 100 µl | Ask for price |
Anti-RRAD Rabbit Polyclonal Antibody |
|||
| TA322782 | Origene Technologies GmbH | 100 µl | Ask for price |
Rabbit polyclonal Anti-RRAD Antibody |
|||
| TA342213 | Origene Technologies GmbH | 100 µl | Ask for price |
Rabbit polyclonal Anti-RRAD Antibody |
|||
| TA342214 | Origene Technologies GmbH | 100 µl | Ask for price |
Mouse Rrad ELISA Kit |
|||
| EF016057 | Nova Lifetech | 96tests | EUR 566 |
Human RRAD ELISA KIT |
|||
| EF005507 | Nova Lifetech | 96tests | EUR 566 |
Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad) |
|||
| MR204351 | Origene Technologies GmbH | 10 µg | Ask for price |
Human RRAD shRNA Plasmid |
|||
| 20-abx954199 | Abbexa |
|
|
Rrad (untagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug) |
|||
| RN208148 | Origene Technologies GmbH | 10 µg | Ask for price |
Human RRAD Protein Lysate |
|||
| MBS8418875-002mg | MyBiosource | 0.02mg | EUR 365 |
Human RRAD Protein Lysate |
|||
| MBS8418875-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
RRAD Peptide - middle region |
|||
| MBS3237802-01mg | MyBiosource | 0.1mg | EUR 180 |
RRAD Peptide - middle region |
|||
| MBS3237802-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |